SATRALIZUMAB (sat ra LIZ ue mab) treats neuromyelitis optica spectrum disorder (NMOSD), a condition that causes inflammation in the nerves of the eyes and spinal cord. It works by decreasing inflammation. It is a monoclonal antibody.

There is no lifestyle interaction information available for this medication.